Skip to main content
Premium Trial:

Request an Annual Quote

OGT to Distribute SciGene Microarray Products

NEW YORK (GenomeWeb News) – Oxford Gene Technology will distribute SciGene's microarray sample processing equipment to researchers throughout the European Union, excluding Germany, OGT announced today.

SciGene's instruments provide cytogeneticists with the ability to automate their entire microarray workflow, from DNA labelling and purification, through hybridisation, to array washing and drying, the Oxford, UK-based firm said.

OGT sells the CytoSure family of high-resolution oligonucleotide arrays, as well as related sample prep technologies.

"The products from both companies are highly complementary and when used together offer cytogenetics customers a complete solution for their microarray-based methods," SciGene President and CEO Jim Stanchfield said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.